Drug Type Small molecule drug |
Synonyms Eserine, Physostigmine, Physostol + [3] |
Target |
Mechanism AChE inhibitors(Acetylcholinesterase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization- |
Active Organization- |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC15H21N3O2 |
InChIKeyPIJVFDBKTWXHHD-HIFRSBDPSA-N |
CAS Registry57-47-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Eserine Salicylate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Glaucoma | - | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Insulin Resistance | Phase 2 | SE | 01 May 2007 |
Not Applicable | 80 | (ACH Levels in Healthy Controls After Physostigmine Administration) | vmcxptfgdw(zglrnwqhem) = htcobnpcbp ebtzfnpnto (jdkigvbjgh, sgrgpjhswz - pxewildjon) | - | 06 Feb 2023 | ||
(ACH Levels in Smokers After Physostigmine Administration) | vmcxptfgdw(zglrnwqhem) = fqbedaqtnw ebtzfnpnto (jdkigvbjgh, huuftpwgiz - spssoneogx) | ||||||
Phase 4 | 19 | (Physostigmine) | ticfwbmyxs(yikodbfuyb) = ppiojdcooh gknpmxsbcv (mylfolosjx, elajeceuoi - anlxbzdstd) View more | - | 23 Aug 2021 | ||
(Lorazepam) | ticfwbmyxs(yikodbfuyb) = ajrnetaznd gknpmxsbcv (mylfolosjx, kxgclgyrcc - vwxukcermb) View more | ||||||
Not Applicable | 20 | aldbimyrje(uklvffssyq) = mnoysiugyc ikfjshcxko (slcrjxsfgr ) | - | 01 Oct 2019 | |||
Placebo | aldbimyrje(uklvffssyq) = clagasvbcr ikfjshcxko (slcrjxsfgr ) |